PTC Therapeutics, Inc. (PTCT) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ptc Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.091 -- 00:00:02.593 Ladies and gentlemen, thank you for standing by. 00:00:02.593 -- 00:00:08.056 Welcome to PTC Therapeutics' second quarter 2026 earnings conference call. 00:00:08.056 -- 00:00:12.339 All participants are in listen-only mode. After the presentation, there will be a question 00:00:12.339 -- 00:00:15.761 and answer session. Today's conference is being recorded. 00:00:15.761 -- 00:00:20.765 I would like to turn the conference over to Ellen Cavaleri, Head of Investor Relations. 00:00:20.765 -- 00:00:23.165 Please go ahead. 00:00:23.797 -- 00:00:28.441 Good afternoon and thank you for joining us to discuss PTC Therapeutics' second quarter 00:00:28.441 -- 00:00:31.824 2026 corporate update and financial results. 00:00:31.824 -- 00:00:34.386 I'm joined today by our Chief Executive Officer, Dr. 00:00:34.386 -- 00:00:39.530 Matthew Klein, our Chief Business Officer, Eric Pauwels, and our Chief Financial Officer, 00:00:39.530 -- 00:00:44.194 Pierre Gravier. Today's call will include forward-looking statements based on our current 00:00:44.194 -- 00:00:49.178 expectations. These statements are subject to certain risks and uncertainties, and actual 00:00:49.178 -- 00:00:53.723 results may differ materially. Please review the slide posted on our Investor Relations 00:00:53.723 -- 00:00:58.246 website in conjunction with the call, which contains information about our forward-looking 00:00:58.246 -- 00:01:03.310 statements and our most recent quarterly report on Form 10-Q and annual report on Form 00:01:03.310 -- 00:01:08.654 10-K filed with the SEC, as well as our other SEC filings for a detailed 00:01:08.654 -- 00:01:13.117 description of applicable risks and uncertainties that could cause our actual performance 00:01:13.117 -- 00:01:17.501 and r...